BCL2 and prostate carcinoma: It has been shown that Bcl-XL [45], but not Bcl-2 overexpression, another anti-apoptotic biomarker [46], protects prostate cancer cells against sulforaphane-induced cell death, indicating that Bcl-XL plays a crucial role in sulforaphane’s mechanism for cell damage.